Home » Newsletters » BioWorld

BioWorld

March 18, 1992

View Archived Issues

ECOGEN ACQUIRES REMAINDER OF PARTNERSHIP

Roberts Shareholders OK Yamanouchi Buy-In

INTERVENTION WITH IMRE COLUMN SUCCEEDS

GENSIA ADOPTS POISON PILL

BIOMIRA GETS RIGHTS TO CANCER PEPTIDE

TEVA EXPANDS PHARMACHEMICAL CAPACITY

CELLULAR TRANSPLANT COMPANY FILES IPO

DATA FAVORS ALZA ORAL DELIVERY SYSTEM

ELAN TO DEBUT WRIST-BORNE DRUG DELIVERY

COMPANY DEFECTS TO NEW AMEX MARKET

SYNTHETIC TAXOL 'EXCITINGLY CLOSE'

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...